Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details)

v3.20.2
STOCKHOLDERS' EQUITY (DEFICIT) (Details)
3 Months Ended
Mar. 31, 2020
$ / shares
shares
Equity (Deficit):  
Number of warrants outstanding, beginning | shares 2,014,299
Number of warrants granted | shares 0
Number of warrants cancelled | shares 0
Number of warrants exercised | shares 0
Number of warrants forfeited | shares 0
Number of warrants outstanding, ending | shares 2,014,299
Number of warrants exercisable | shares 2,014,299
Weighted average exercise price outstanding, beginning $ .45
Weighted average exercise price granted .00
Weighted average exercise price cancelled .00
Weighted average exercise price exercised .00
Weighted average exercise price forfeited .00
Weighted average exercise price outstanding, ending .45
Weighted average exercise price exercisable 0.45
Weighted average fair value of warrants granted during the period $ 0
Weighted average remaining contractual life outstanding, beginning 3 years 3 months 22 days
Weighted average remaining contractual life outstanding, ending 3 years 22 days
Weighted average remaining contractual life exercisable 3 years 22 days